Berencsi, K.
Sami, A.
Ali, M.S.
Marinier, K.
Deltour, N.
Perez-Gutthann, S.
Pedersen, L.
Rijnbeek, P.
Van der Lei, J.
Lapi, F.
Simonetti, M.
Reyes, C.
Sturkenboom, M.C.J.M.
Prieto-Alhambra, D. http://orcid.org/0000-0002-3950-6346
Funding for this research was provided by:
Servier (NA)
Article History
Received: 19 June 2019
Accepted: 26 September 2019
First Online: 6 November 2019
Change Date: 5 February 2020
Change Type: Correction
Change Details: The original version of this article, published on 26 November 2019 contained a mistake.
Compliance with ethical standards
:
: Karine Marinier is an employee of Servier. Nicolas Deltour is an employee of Servier. Susana Perez-Guthann received grants and consultation contracts from pharmaceutical companies including Servier for other regulatory safety studies and projects. Miriam CJM Sturkenboom, MCJMS, was co-coordinating the work from Erasmus University Medical Center. Daniel Prieto-Alhambra, DPA, is funded by the National Institute for Health Research Clinician Scientist award (CS-2013-13-012). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Lars Pedersen, Peter Rijnbeek, Johan Van der Lei, Francesco Lapi, Monica Simonetti, Carlen Reyes, Klara Berencsi, Arvind Sami and M Sanni Ali.
: The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.